CH functionalization logic in total synthesis
In practice, it seems better to tailor the choice to different patients, depending on the preference of the route of administration (oral vs injectable), the presence of intolerance or side-effects, and contraindications
"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial"
"Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum"
Dimensions: 5100 x 3387 px | 43.2 x 28.7 cm | 17 x 11.3 inches | 300dpi Date taken: 8 August 2008 Location: Northern Ireland, UK
et al., Endocrine Reviews Its important to note: IGF-1 LR3 is not a fat-burner or testosterone mimic